| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 07/19/2007 | US20070167441 Xanthones, thioxanthones and acridinones as dna-pk inhibitors |
| 07/19/2007 | US20070167440 Novel pyrrolidine compound and a process for preparing the same |
| 07/19/2007 | US20070167439 N4-(1-tert-Butoxycarbonylazetidin-3-yl)-5-fluoro-N2-(4-morpholinophenyl)-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE ("Fc epsilon RI") and IgG ("Fc gamma RI") antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis, multiple sclerosis |
| 07/19/2007 | US20070167437 Antiproliferative agents; anticarcinogenic agents; cis-[4,5-Bis-(4-chloro-phenyl)-2-(4-ethoxy-2-trifluoromethyl-pyrimidin-5-yl)-4,5-dihydro-imidazol-1-yl]-[4-(2-methanesulfonyl-ethyl)-piperazin-1-yl]-methanone; inhibitors of the MDM2-p53 interaction |
| 07/19/2007 | US20070167430 Compounds useful in therapy |
| 07/19/2007 | US20070167423 e.g. 3-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-1,3-oxazolidin-2-one; serotonin receptor antagonist and inverse agonists, agonists or partial agonists, serotonin reuptake inhibitor; antidepressant, anxiolytic agent |
| 07/19/2007 | US20070167421 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides |
| 07/19/2007 | US20070167414 Novel antibacterial agents |
| 07/19/2007 | US20070167406 Dihydropyridine derivatives for use as human neutrophil elastase inhibitors |
| 07/19/2007 | CA2636625A1 Oxazolone derivative |
| 07/19/2007 | CA2635997A1 Morpholino pyrimidine derivatives and their use in therapy |
| 07/19/2007 | CA2635047A1 Novel thiophene derivatives as s1p1/edg1 receptor agonists |
| 07/19/2007 | CA2634566A1 Substituted oxazole derivatives with an analgesic action |
| 07/19/2007 | CA2634562A1 Substituted oxadiazole derivatives and their use as opioid receptor ligands |
| 07/18/2007 | EP1807412A1 Cyclic diarly ureas suitable as tyrosine kinase inhibitors |
| 07/18/2007 | EP1807403A2 Tetracyclic indole derivatives as antiviral agents |
| 07/18/2007 | EP1807082A2 Factor xa compounds |
| 07/18/2007 | EP1807074A1 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 07/18/2007 | EP1725239B1 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy |
| 07/18/2007 | EP1711184B1 (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity |
| 07/18/2007 | EP1565436A4 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 07/18/2007 | EP1558598B1 Triazole compounds for the treatment of dysmenorrhoea |
| 07/18/2007 | EP1458711B1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3 |
| 07/18/2007 | EP1373224B1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 07/18/2007 | EP1054885B1 Benzisoxazole derivatives having d4-antagonistic activity |
| 07/18/2007 | CN1326853C Novel 4-2-furoylaminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same |
| 07/18/2007 | CN1326850C Tricyclic farnesyl protein transferase inhibitors |
| 07/18/2007 | CN1326838C Benzo[d]azepine derivatives for the treatment of neurological disorders |
| 07/18/2007 | CN101001854A Highly selective novel amidation method |
| 07/18/2007 | CN101001853A Oxindole oxazolidinones as antibacterial agents |
| 07/18/2007 | CN101001846A Novel alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 07/18/2007 | CN101001844A Mercaptoimidazoles as CCR2 receptor antagonists |
| 07/17/2007 | US7244853 Dioxanes and uses thereof |
| 07/17/2007 | US7244847 Bactericides |
| 07/17/2007 | US7244763 Compounds that modulate PPAR activity and methods of preparation |
| 07/17/2007 | US7244758 N-type calcium channel blockers |
| 07/17/2007 | US7244753 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/17/2007 | US7244752 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors |
| 07/17/2007 | US7244745 Heterocyclic compounds, methods for the preparation thereof, and uses thereof |
| 07/17/2007 | US7244744 Useful in treatment of diseases through the inhibition of sodium ion flux through voltage-dependent sodium channels; treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels |
| 07/17/2007 | US7244739 For treatment of neurodegenerative disorder, Alzheimer's disease; kits |
| 07/17/2007 | US7244738 Urogenital disorders; sexual diosrders; benign prostatic hyperplasia; analgesics |
| 07/17/2007 | US7244731 preparing 6-methyl-2-[4-(4-morpholino)anilino]nicotinic acid by reacting 2-chloro-6-methylnicotinic acid with 4-(4-morforino)aniline; effective for inhibiting the replication of hepatitis C virus |
| 07/17/2007 | US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy |
| 07/17/2007 | US7244729 tyrosine kinase inhibitors; for the treatment especially of a proliferative disease, such as a tumur |
| 07/17/2007 | US7244726 Heterocyclic compounds possessing affinity at 5HT1 -type receptors and use thereof in therapy |
| 07/17/2007 | US7244723 Kinesin spindle protein (KSP) inhibitors, e.g., 3-benzyl-2-(1-{(4-bromobenzyl)[2-(dimethylamino)ethyl]amino}propyl)furo[2,3-d]pyrimidin-4(3H)-one; antiproliferative and -carcinogenic agents; side effects reduction; cancers of the brain, genitourinary tract, lymphatic system, stomach, larynx and lung |
| 07/17/2007 | US7244722 5-HT2A receptor related disorders; such as 1-(2-(2-fluoro-4-nitrophenoxy)ethyl)-3-(1piperazinyl)-2(1H)-pyrazinone |
| 07/17/2007 | CA2432643C 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors |
| 07/12/2007 | WO2007079186A2 1, 3-oxazolidin-2-one derivatives useful as cetp inhibitors |
| 07/12/2007 | WO2007079162A1 Isoxazolines for controlling invertebrate pests |
| 07/12/2007 | WO2007078523A2 5-phenyl-3-benzyl-0xaz0lidin-2-0ne derivatives and related compounds as metabotropic glutamate receptor potentiators for the treatment of neurological and psychiatric disorders |
| 07/12/2007 | WO2007078251A1 Compounds |
| 07/12/2007 | WO2007078113A1 Isoxazole derivatives and use thereof |
| 07/12/2007 | WO2007077961A2 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands |
| 07/12/2007 | WO2007077201A1 Piperazine compounds with a herbicidal action |
| 07/12/2007 | WO2007077186A1 Pdf inhibitors |
| 07/12/2007 | WO2007077005A1 3 , 5-substitγued piperidine compounds as renin inhibitors |
| 07/12/2007 | WO2007059257A8 N4-phenyl-quinaz0line-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
| 07/12/2007 | WO2007052123A3 Pyrazine derivatives as sodium channel modulators for the treatment of pain |
| 07/12/2007 | WO2007044490A3 Process for making heteroaryl amine intermediate compounds |
| 07/12/2007 | WO2007027780A3 Benzopyran and pyranopyridine derivatives as potassium channel openers |
| 07/12/2007 | WO2007023507A3 Oxazolidinones bearing antimicrobial activity composition and methods of preparation |
| 07/12/2007 | US20070161800 Nitriting; industrial scale; crop protection |
| 07/12/2007 | US20070161787 (1S)-1,5-anhydro-1-[3-(1-benzothien-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity |
| 07/12/2007 | US20070161690 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners |
| 07/12/2007 | US20070161689 Indoles having anti-diabetic activity |
| 07/12/2007 | US20070161687 1,2,4-Oxadiazole benzoic acid compositions and their use for nonsense suppression and the treatment of disease |
| 07/12/2007 | US20070161686 Cyclopropylmethyl-{3-methoxy-4-[5-(5-methyl-3-phenyl-isoxazol-4-yl)-[1,3,4]oxadiazol-2-yl]-phenyl}-amine; -{3-Methoxy-4-[5-(5-methyl-3-phenyl-isoxazol-4-yl)-[1,3,4]oxadiazol-2-yl]-phenyl}-thiomorpholine; useful for the treatment of cognitive disorders like Alzheimer's disease |
| 07/12/2007 | US20070161681 Ether derivatives useful as inhibitors of pde4 isozymes |
| 07/12/2007 | US20070161664 Therapeutic compounds |
| 07/12/2007 | US20070161654 e.g. 5-methyl-3-phenyl-4-(1-phenyl-1H-imidazol-4-yl)-isoxazole; GABA A alpha 5 receptor inverse agonist; cognition activator, Alzheimer's disease |
| 07/12/2007 | US20070161651 Tie-2 modulators and methods of use |
| 07/12/2007 | US20070161646 Piperidine Derivatives and Their Use as Modulators of Chemokine Receptor Activity (Especially CCR5) |
| 07/12/2007 | US20070161643 Pyridin-2-one compounds useful as inhibitors of thrombin |
| 07/12/2007 | US20070161641 2-(4-thieno[2,3-d]isoxazol-3-yl-piperidin-1-ylmethyl)-(2R,3R)-cyclopropanecarboxylic acid (trans4-methyl-cyclohexyl)-amide; psychological disorders, neurodegenerative diseases, antidepressant; drug abuse, sleep disorders |
| 07/12/2007 | US20070161635 Kinase inhibitors |
| 07/12/2007 | US20070161634 Compounds as CCR5 antagonists |
| 07/12/2007 | US20070161633 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
| 07/12/2007 | US20070161626 Substituted Indazoles, Compositions Containing The Same, And The Preparation And Use Thereof |
| 07/12/2007 | US20070161623 Urea derivatives |
| 07/12/2007 | US20070161622 Diamino alcohols and their use as renin inhibitor |
| 07/12/2007 | US20070161574 Hcv ns-3 serine protease inhibitors |
| 07/12/2007 | US20070161513 3-[1-halo-1-arylmethanesulfonyl]- and 3-[1-halo-1-heteroarylmethanesulfonyl]- isoxazoline derivatives, processes for preparing them, and use as herbicides and plant growth regulators |
| 07/12/2007 | US20070161112 Cell biology, neurology, nutrition, immunology, reproductive biology, cancer and proteomics; facilitate binding, detecting, monitoring and quantitating of heavy metalnovel luminescence-based materials ; |
| 07/12/2007 | US20070160931 methine dye containing C4O2.C6.C4O2 ring; thermal stability, light fastness; reproduction/playback of the high density information recordings |
| 07/12/2007 | CA2635541A1 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands |
| 07/12/2007 | CA2634195A1 Piperazine compounds with a herbicidal action |
| 07/12/2007 | CA2633624A1 3,5-substituted piperidine compounds as renin inhibitors |
| 07/12/2007 | CA2632694A1 Isoxazolines for controlling invertebrate pests |
| 07/12/2007 | CA2629148A1 Pdf inhibitors |
| 07/11/2007 | EP1806346A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 07/11/2007 | EP1806344A1 Optically active 4,4-disubstituted oxazolidine derivative and method for producing same |
| 07/11/2007 | EP1805202A2 Conjugates with anti-inflammatory activity |
| 07/11/2007 | EP1805171A2 Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 07/11/2007 | EP1805170A1 Mif-inhibitors |
| 07/11/2007 | EP1805169A1 Histamine h3 receptor inhibitors, their preparation and therapeutic uses |
| 07/11/2007 | EP1805164A2 6-(pyridinyl)-4-pyrimidone derivates as tau protein kinase 1 inhibitors |
| 07/11/2007 | EP1805147A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 07/11/2007 | EP1804799A2 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |